Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CKS1B | P61024 | 1/20 | 0.52 |
| ▸ | SKP1 | P63208 | 1/20 | 0.52 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.52 |
| ▸ | NAMPT | P43490 | 1/20 | 0.48 |
| ▸ | TTR | P02766 | 1/20 | 0.46 |
| ▸ | ACACB | O00763 | 12/20 | 0.45 |
| ▸ | ACACA | Q13085 | 11/20 | 0.45 |
| ▸ | DRD2 | P14416 | 2/20 | 0.44 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7391345 | 0.86 | DRD2 (0.50) | CKS1BSKP1SKP2NAMPTACACB | |
| SCHEMBL7390125 | 0.85 | NAMPT (0.49) | CKS1BSKP1SKP2NAMPTACACB | |
| SCHEMBL7395381 | 0.84 | NAMPT (0.51) | CKS1BSKP1SKP2NAMPTACACB | |
| SCHEMBL7388880 | 0.84 | CKS1B (0.52) | CKS1BSKP1SKP2NAMPTACACB | |
| SCHEMBL7389331 | 0.83 | NAMPT (0.47) | CKS1BSKP1SKP2NAMPTACACB | |
| SCHEMBL7392880 | 0.83 | NAMPT (0.47) | CKS1BSKP1SKP2NAMPTACACB | |
| SCHEMBL25081005 | 0.78 | NAMPT (0.67) | CKS1BSKP1SKP2NAMPTACACB | |
| SCHEMBL25766607 | 0.75 | CKS1B (0.62) | CKS1BSKP1SKP2ACACBACACA | |
| SCHEMBL4703939 | 0.75 | CKS1B (0.62) | CKS1BSKP1SKP2ACACBACACA | |
| SCHEMBL9005458 | 0.74 | PRKCQ (0.62) | TTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5576320-A | 1-heteruarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them | SANOFI (FR) | 1996-11-19 | — | — | US | disclosed |
| US-5565474-A | 1-heteroarylazetidines and -pyrrolidines process for their preparation and pharmaceutical compositions containing them | SANOFI (FR) | 1996-10-15 | — | — | US | disclosed |
| US-5410057-A | 1-heteroarylazetidines and -pyrrolidines | SANOFI (FR) | 1995-04-25 | — | — | US | disclosed |